Page Metadata
Page Type: Medical Treatment Page - Focal Therapy
Page URL: https://www.thefocaltherapyclinic.co.uk/focal-therapy/
Main Topic: Focal Therapy for Prostate Cancer - Minimally Invasive Treatment Options
Medical Condition: Localised Prostate Cancer
Medical Procedures: HIFU (High-Intensity Focused Ultrasound), Cryotherapy, NanoKnife IRE (Irreversible Electroporation)
Date Published: 2023-04-07
Date Modified: 2025-02-17
Medical Specialty: Urology
Language: en-GB
Page Title: Focal Therapy for Prostate Cancer Treatment - The Focal Therapy Clinic
Page Description: Focal therapy is an advanced treatment option for localised prostate cancer, offering a minimally invasive alternative to radical surgery and radiotherapy. Find out more
Organization Information
Organization Name: The Focal Therapy Clinic
Organization Type: Medical Organization specialising in focal therapy for prostate cancer
Organization URL: https://www.thefocaltherapyclinic.co.uk/
Logo URL: https://www.thefocaltherapyclinic.co.uk/wp-content/themes/onevision/images/logo.svg
Social Media - Facebook: https://www.facebook.com/TheFocalTC
Social Media - Twitter: https://twitter.com/TheFocalTC
Social Media - LinkedIn: https://www.linkedin.com/company/the-focal-therapy-clinic/
Organization Description: Leading UK clinic specialising in focal therapy for prostate cancer
Medical Specialties Offered: Urology, Focal Therapy for Prostate Cancer
Breadcrumb Navigation
Level 1: Home - https://www.thefocaltherapyclinic.co.uk/
Level 2: Focal Therapy (Current Page)
Medical Procedure Information
Primary Treatment: Focal Therapy for Localised Prostate Cancer
Treatment Approach: Minimally invasive, targeted cancer destruction while preserving healthy tissue
Medical Specialty: Urology
Treatment Category: NICE-approved focal therapy options
Treatment Option 1: HIFU (High-Intensity Focused Ultrasound)
NICE Procedure Codes: IPG424, IPG756
Procedure Type: Therapeutic, non-invasive
Technology: Focused ultrasound waves to heat and destroy cancer cells
Best For: Tumours located toward the back (posterior) of the prostate
Delivery Method: No needles inserted into the prostate - ultrasound probe placed in rectum
Treatment Duration: 60-90 minutes under general anaesthesia
Treatment Option 2: Cryotherapy
Procedure Type: Therapeutic, needle-based
Technology: Freezes cancerous tissue to destroy the tumour
Best For: Tumours located toward the front (anterior) of the prostate
Delivery Method: Probes inserted into prostate to freeze cancerous tissue
Treatment Duration: 60-90 minutes under general anaesthesia
Treatment Option 3: NanoKnife IRE (Irreversible Electroporation)
NICE Procedure Code: IPG443
Procedure Type: Therapeutic, needle-based
Technology: Electrical pulses create microscopic holes in cancer cells causing cell death
Best For: Anterior tumours that HIFU may not reach as effectively
Delivery Method: Needles inserted to deliver electrical pulses
Treatment Duration: 60-90 minutes under general anaesthesia
Procedure Details and Process
Procedure Duration: 60-90 minutes
Anaesthesia Type: General anaesthesia
Hospital Stay: Day case procedure - most patients go home same day
Catheter: Placed at end of procedure to aid recovery
Imaging Technology: MRI-ultrasound fusion for precise tumour targeting
Real-time Monitoring: Imaging ensures treatment targets only cancerous area with margin
Before the Procedure
Patient arrives at hospital having fasted
Pre-procedure checks performed by nursing staff
Enema may be given to clear bowels for better ultrasound imaging
General anaesthesia administered in operating theatre
During the Procedure
Positioning: Lithotomy position for perineal access
Transrectal ultrasound probe placed in rectum
For HIFU: Probe also delivers treatment
For Cryotherapy and NanoKnife: Probe used for imaging only
Ultrasound images linked to MRI scan using fusion technology
HIFU: Focused ultrasound delivered in overlapping zones (3-4 sessions)
Cryotherapy: Needles inserted to freeze cancerous tissue
NanoKnife: Needles inserted to deliver electrical pulses
Catheter placed in bladder at end of procedure
After the Procedure
Recovery room: Approximately 30 minutes before returning to ward
Food and drink given once fully awake
Catheter management instruction provided by nurses
Discharge: Most patients go home within a few hours
Transport: Someone must drive patient home (cannot drive for 36 hours after anaesthesia)
Clinical Outcomes and Success Rates
Cancer-Free Rate at One Year: Over 90% based on MRI and PSA criteria
Clinically Significant Cancer Elimination: 90% at one year (clinic data from 270 patients)
Full Continence Rate: 99% of men experience no incontinence issues
Erectile Function Preservation: 85% of men retain erections suitable for intercourse
Long-term Radical Treatment Avoidance: 75-80% of men remain free from needing surgery or radiotherapy for 6-10 years
MRI-Ultrasound Fusion Technology: Improves treatment accuracy to 90%+ success rates
Data Source: Clinic review of 270 patients
Global Research: 75-80% long-term success rates documented worldwide
Recovery Information
First 48 Hours
Light activities including walking encouraged
Cannot drive for 36 hours after general anaesthesia
Mild discomfort, bladder spasms, or increased urinary frequency possible
Symptoms managed with medications
First Week (Catheter In Place)
Catheter remains in place for 5-7 days
Most light activities possible, including working from home
Office-based workers often return to work within a few days
After Catheter Removal
Return to normal physical activities including sports within one week
Bladder function normalisation may take a few weeks
Temporary urgency or frequency possible
Long-term Recovery (3-6 Months)
Erectile function: Most men regain normal erections within 3-6 months
Support available: Low-dose erectile function medications like Tadalafil (Cialis)
Urinary function: Full continence typically restored within weeks
Incontinence: Less than 1% experience long-term incontinence
Fatigue: Mild fatigue resolves with rest and gradual return to activity
Comparison to Other Treatments
Focal Therapy Recovery: Same-day discharge, catheter 5-7 days, return to activities within 1-2 weeks
Radical Surgery Recovery: Hospital stay several days, catheter 1-2 weeks, recovery period 4-6 weeks
Radiotherapy: No hospital stay, but treatment spread over 4-8 weeks with side effects developing over time
Side Effects and Management
Common Side Effects (Temporary)
Increased urinary frequency or urgency - usually resolves within a few weeks
Mild discomfort in the perineum - typically lasts 2-3 days
Blood in urine or semen - can persist for a few weeks
Temporary erectile dysfunction - most men regain function within 3-6 months with medication support
Less Common Side Effects
Urinary retention - may require catheter for a few days
Urinary tract infection (UTI) - treatable with antibiotics
Bladder spasms - managed with antispasmodic medications (Buscopan, Solifenacin)
Rare Side Effects
Persistent erectile dysfunction: 5-15% of cases depending on tumour location and nerve proximity
Incontinence: Very rare, affecting less than 1% of patients
Recto-urethral fistula: Extremely rare, more associated with cryotherapy
Side Effect Comparison
Focal Therapy Incontinence: Less than 1%
Radical Surgery Incontinence: 10-30%
Focal Therapy Erectile Dysfunction: 5-15%
Radical Surgery Erectile Dysfunction: 30-70%
Radiotherapy Erectile Dysfunction: 30-50%
Focal Therapy: Minimal side effects, significantly less severe and shorter duration than radical treatments
Patient Eligibility
Cancer Stage: Early or intermediate-stage prostate cancer (T1 or T2)
Gleason Score: Typically 7 or lower (3+4 or 4+3)
Cancer Type: Localised prostate cancer confined within the prostate gland
Tumour Location: Cancer must be clearly visible on MRI scan and localised to specific area
PSA Levels: Generally for men with PSA suggesting localised disease
General Health: Patients should be fit enough for general anaesthesia
Not Suitable For: Advanced cancer, widespread disease, or Gleason score above 7
Assessment Process: Expert urologists review PSA levels, MRI scans, and biopsy results during initial consultation
Follow-up Care Schedule
First Year
PSA Blood Tests: Conducted every 3 months to monitor PSA levels
MRI Scan: Performed at end of first year to ensure treated area has disappeared
Purpose: Verify no new abnormalities developed in remaining prostate tissue
Years 2-3
PSA Tests: Conducted every 6 months
Long-term Follow-up
Annual PSA Tests: Continued annually to monitor for signs of recurrence
Optional MRI Scans: Some men opt for additional MRI scans at 3 or 5 years
If Cancer Recurs
Recurrence Rate: 5-10% of cases where cancer not fully treated or recurs
Repeat Focal Therapy: Another session can be performed
Radical Treatment Options: Surgery (radical prostatectomy) or radiotherapy available if needed
Advantage: Focal therapy does not prevent later radical treatments if necessary
Medical Consultants and Professionals (E-E-A-T)
Total Consultants Featured in Videos: 3 expert urologists
Total Team Members: 6 medical professionals
Professional Affiliations: British Association of Urological Surgeons (BAUS), European Association of Urology (EAU), Royal College of Surgeons (RCS)
Consultant 1: Mr Tim Dudderidge
Full Name: Mr Tim Dudderidge
Job Title: Consultant Urologist
Professional Credentials: FRCS (Urol), MD, MBBS
Profile URL: https://www.thefocaltherapyclinic.co.uk/consultants/tim-dudderidge/
Video Appearances: 8 videos (most featured consultant)
Topics Covered: Different types of focal therapy, preparation, procedure details, recovery, anaesthesia, post-procedure care
Areas of Expertise - Mr Tim Dudderidge
Clinical Expertise Area: Focal therapy for prostate cancer
Clinical Expertise Area: Robotic prostatectomy
Clinical Expertise Area: HIFU treatment
Clinical Expertise Area: Active surveillance
Clinical Expertise Area: Clinical trials and research
Professional Affiliations - Mr Tim Dudderidge
Professional Member: British Association of Urological Surgeons (BAUS) - https://www.baus.org.uk/
Professional Member: European Association of Urology (EAU) - https://uroweb.org/
Experience and Qualifications - Mr Tim Dudderidge
Research Leadership: Lead investigator on ProtecT trial
Procedures Performed: 1,500+ robotic prostatectomies performed
Hospital Affiliation: Consultant at University Hospital Southampton
Consultant 2: Mr Marc Laniado
Full Name: Mr Marc Laniado
Job Title: Consultant Urologist
Professional Credentials: FRCS (Urol), MBBS
Profile URL: https://www.thefocaltherapyclinic.co.uk/consultants/marc-laniado/
Video Appearances: 3 videos
Topics Covered: NICE recommendations, MRI-US fusion technology, success rates, erectile function after treatment
Areas of Expertise - Mr Marc Laniado
Clinical Expertise Area: Focal therapy for prostate cancer
Clinical Expertise Area: HIFU treatment
Clinical Expertise Area: NanoKnife IRE treatment
Clinical Expertise Area: Robotic surgery
Clinical Expertise Area: Minimally invasive urology
Professional Affiliations - Mr Marc Laniado
Professional Member: British Association of Urological Surgeons (BAUS) - https://www.baus.org.uk/
Professional Member: European Association of Urology (EAU) - https://uroweb.org/
Experience and Qualifications - Mr Marc Laniado
Role: Consultant Urological Surgeon
Specialization: Specialist in focal therapy techniques
Consultant 3: Mr Raj Nigam
Full Name: Mr Raj Nigam
Job Title: Consultant Urologist
Professional Credentials: FRCS (Urol), MBBS, BSc
Profile URL: https://www.thefocaltherapyclinic.co.uk/consultants/raj-nigam/
Video Appearances: 3 videos
Topics Covered: Focal therapy availability, effectiveness testing after treatment
Areas of Expertise - Mr Raj Nigam
Clinical Expertise Area: HIFU (High-Intensity Focused Ultrasound)
Clinical Expertise Area: Focal therapy for prostate cancer
Clinical Expertise Area: MRI-targeted biopsies
Clinical Expertise Area: Active surveillance protocols
Clinical Expertise Area: Minimally invasive procedures
Professional Affiliations - Mr Raj Nigam
Professional Member: British Association of Urological Surgeons (BAUS) - https://www.baus.org.uk/
Professional Member: European Association of Urology (EAU) - https://uroweb.org/
Professional Member: Royal College of Surgeons (RCS) - https://www.rcseng.ac.uk/
Experience and Qualifications - Mr Raj Nigam
Experience: 15+ years in urology
Procedures Performed: 500+ HIFU procedures performed
Additional Team Members
Mr Alan Doherty: Consultant Urologist - MBBS, BSc, MD, FRCS (Urol), FEBU
Dr Clare Allen: Consultant Uro-Radiologist
Dr Christos Mikropoulos: Clinical Oncologist - MBBS, MSc, MD (Res), MRCP, FRCR
Alternative Treatments
Radical Surgery (Prostatectomy)
Scope: Removes entire prostate gland, affecting surrounding structures
Incontinence Risk: 10-30%
Erectile Dysfunction Risk: 30-70%
Recovery: Hospital stay several days, catheter 1-2 weeks, recovery period 4-6 weeks
Repeatability: Cannot be repeated
Radiotherapy
Scope: Treats entire prostate with radiation, can damage nearby healthy tissue
Side Effects: Bowel issues, urinary problems
Erectile Dysfunction Risk: 30-50%
Treatment Schedule: Spread over 4-8 weeks with side effects developing over time
Repeatability: Difficult to re-treat the same area
Active Surveillance
Approach: Monitoring cancer without immediate treatment
Suitable For: Very low-risk prostate cancer
Not Mentioned: Specific comparison data in source material
Key Differentiators for Focal Therapy
Treatment Scope: Targets only cancerous area, preserving healthy tissue
Incontinence: Less than 1% (vs 10-30% surgery)
Erectile Function: 5-15% dysfunction (vs 30-70% surgery)
Recovery: Same-day discharge, 1-2 week return to activities
Repeatability: Can be repeated if cancer recurs
Cancer Control: 75-80% avoid radical treatment for 6-10 years
NHS and Insurance Availability
NHS Availability
Status: Available on NHS, though availability varies by hospital and region
NHS Centres Offering Focal Therapy: University College London (UCL), Imperial College London
Emerging NHS Centres: Southampton expanding programs
NICE Approval Status: National Institute for Health and Care Excellence has approved focal therapy
HIFU Approval: NICE codes IPG424 and IPG756
NanoKnife IRE Approval: NICE code IPG443
Private Sector Availability
History: Focal therapy widely available in private sector for many years
Insurance Coverage: All major insurance companies cover focal therapy under specific procedure codes
The Focal Therapy Clinic: Treats both NHS and private patients
Access: Ensures all men have access to this advanced treatment option
Frequently Asked Questions About Focal Therapy
FAQ: What is Focal Therapy for Prostate Cancer?
Answer: Focal therapy is a minimally invasive treatment for localised prostate cancer that targets only the cancerous tissue while preserving the healthy parts of the prostate. This approach aims to effectively treat the cancer while minimising side effects commonly associated with more invasive treatments like radical prostatectomy or radiotherapy. At The Focal Therapy Clinic, we specialise in multiple forms of focal therapy, including HIFU (High-Intensity Focused Ultrasound), Cryotherapy, and NanoKnife (Irreversible Electroporation).
FAQ: What are the three main types of Focal Therapy?
Answer: The three main types of focal therapy for prostate cancer are: HIFU (High-Intensity Focused Ultrasound): Uses focused ultrasound waves to heat and destroy cancer cells. It is non-invasive, with no needles inserted into the prostate. HIFU is most effective for tumours located toward the back of the prostate. Cryotherapy: A needle-based therapy that freezes cancerous tissue, destroying the tumour while preserving healthy structures. It works well for tumours located toward the front of the prostate. NanoKnife (Irreversible Electroporation, IRE): A needle-based therapy using electrical pulses to create microscopic holes in cancer cells, causing them to die. It is effective for anterior tumours that HIFU may not reach as well.
FAQ: How does Focal Therapy work?
Answer: Focal therapy works by precisely targeting and destroying cancerous tissue within the prostate while leaving healthy tissue intact. This is achieved using advanced imaging techniques, such as MRI-ultrasound fusion, to accurately locate the tumour. Depending on the type of focal therapy used: HIFU: Uses focused ultrasound waves to heat and destroy cancer cells. The ultrasound probe is placed in the rectum, and the treatment is delivered without needles. Cryotherapy: Involves inserting probes into the prostate that freeze the cancerous tissue, effectively destroying it. NanoKnife (IRE): Uses electrical pulses delivered through needles to disrupt cancer cells at the cellular level. Throughout the procedure, real-time imaging ensures the treatment targets only the cancerous area, with a margin around it to capture any microscopic disease. The entire process typically lasts 60-90 minutes under general anaesthesia, and a catheter is placed at the end to aid recovery.
FAQ: Who is eligible for Focal Therapy?
Answer: Focal therapy is typically suitable for men with localised prostate cancer, meaning the cancer is confined within the prostate gland. Eligibility depends on several factors, including: Cancer Stage: Early or intermediate-stage prostate cancer (T1 or T2). Gleason Score: Typically 7 or lower (3+4 or 4+3). Tumour Location: The cancer must be clearly visible on an MRI scan and localised to a specific area of the prostate. PSA Levels: Generally for men with a PSA level that suggests localised disease. General Health: Patients should be fit enough to undergo a procedure under general anaesthesia. If you have advanced cancer, widespread disease, or a Gleason score above 7, focal therapy may not be suitable. Our expert urologists will assess your individual case, review your PSA levels, MRI scans, and biopsy results during your initial consultation to determine if focal therapy is the right option for you.
FAQ: What are the success rates and outcomes of Focal Therapy?
Answer: Focal therapy has demonstrated strong success rates for men with localised prostate cancer. The outcomes vary based on the treatment type, tumour characteristics, and patient factors, but research shows: At The Focal Therapy Clinic, we use MRI-ultrasound fusion technology to enhance treatment accuracy, which improves success rates: Over 90% of men are cancer-free at one year based on MRI and PSA criteria. Globally, 75-80% of men remain free from needing radical treatment (surgery or radiotherapy) for 6-10 years after focal therapy. The clinic's data, based on a review of 270 patients, shows: 90% of clinically significant cancer is eliminated at one year. 99% of men are fully continent (no incontinence issues). 85% of men retain erections suitable for intercourse.
FAQ: What are the side effects of Focal Therapy?
Answer: Focal therapy is designed to minimise side effects by targeting only the cancerous tissue while preserving healthy structures. However, some side effects may occur: Common Side Effects (Temporary): Increased urinary frequency or urgency – usually resolves within a few weeks. Mild discomfort in the perineum – typically lasts 2-3 days. Blood in urine or semen – can persist for a few weeks. Temporary erectile dysfunction – most men regain function within 3-6 months, especially with support like low-dose erectile function medications. Less Common Side Effects: Urinary retention – requiring a catheter for a few days. Urinary tract infection (UTI) – treatable with antibiotics. Bladder spasms – managed with antispasmodic medications like Buscopan or Solifenacin. Rare Side Effects: Persistent erectile dysfunction (5-15% of cases, depending on tumour location and nerve proximity). Incontinence (very rare, affecting less than 1% of patients). Recto-urethral fistula (extremely rare, more associated with certain types of focal therapy like cryotherapy). Most side effects are significantly less severe and shorter in duration than those associated with radical treatments like surgery or radiotherapy.
FAQ: How is Focal Therapy different from radical surgery or radiotherapy?
Answer: Focal therapy differs from radical surgery (prostatectomy) and radiotherapy in several key ways: Treatment Scope: Focal Therapy: Targets only the cancerous area of the prostate, preserving healthy tissue. Radical Surgery: Removes the entire prostate gland, affecting surrounding structures. Radiotherapy: Treats the entire prostate with radiation, which can damage nearby healthy tissue. Side Effects: Focal Therapy: Minimal side effects, with low rates of incontinence (less than 1%) and erectile dysfunction (5-15%). Radical Surgery: Higher risk of incontinence (10-30%) and erectile dysfunction (30-70%). Radiotherapy: Can cause bowel issues, urinary problems, and erectile dysfunction (30-50%). Recovery Time: Focal Therapy: Most patients go home the same day, with catheter removal within 5-7 days. Radical Surgery: Requires a hospital stay of several days, with a catheter for 1-2 weeks and a recovery period of 4-6 weeks. Radiotherapy: No hospital stay, but treatment is spread over 4-8 weeks, with side effects developing over time. Repeatability: Focal Therapy: Can be repeated if cancer recurs or is incompletely treated. Radical Surgery: Cannot be repeated. Radiotherapy: Difficult to re-treat the same area. Cancer Control: Focal Therapy: Effective for localised cancer, with 75-80% of men avoiding radical treatment for 6-10 years. Radical Surgery & Radiotherapy: May offer slightly higher long-term cancer control rates but at the cost of greater side effects.
FAQ: What happens during the Focal Therapy procedure?
Answer: The focal therapy procedure is performed under general anaesthesia and typically lasts 60-90 minutes. Here's what happens: Before the Procedure: Arrival: You'll arrive at the hospital having fasted (no food or drink for several hours). Pre-Procedure Checks: Nursing staff will perform necessary checks, and you may be given an enema to clear the bowels for better ultrasound imaging. Anaesthesia: You'll be placed under general anaesthesia in the operating theatre. During the Procedure: Positioning: Your legs will be positioned in lithotomy (similar to a gynecological exam) to allow access to the perineum. Imaging & Planning: A transrectal ultrasound probe is placed in the rectum. For HIFU, this probe also delivers the treatment. For cryotherapy and NanoKnife, it is used for imaging only. The ultrasound images are linked to your MRI scan using MRI-ultrasound fusion technology to precisely locate the tumour. Treatment: HIFU: Focused ultrasound waves are delivered in overlapping zones (typically 3-4 sessions) to heat and destroy cancer cells. Cryotherapy: Needles are inserted into the prostate to freeze the cancerous tissue. NanoKnife: Needles are inserted to deliver electrical pulses that destroy cancer cells. Catheter Placement: A catheter is placed in the bladder at the end of the procedure to help drain urine during recovery. After the Procedure: Recovery Room: You'll wake up in the recovery room, where you'll spend about 30 minutes before returning to the ward. Eating & Drinking: Once fully awake, you'll be given food and drink. Catheter Management: Nurses will show you how to manage the catheter. Going Home: Most patients go home within a few hours, though someone must drive you, as you cannot drive for 36 hours after general anaesthesia.
FAQ: How long does recovery take after Focal Therapy?
Answer: Recovery after focal therapy is typically quick compared to radical treatments: First 48 Hours: You can resume light activities, including walking, which is encouraged. You cannot drive for 36 hours after general anaesthesia. You may experience mild discomfort, bladder spasms, or increased urinary frequency, which can be managed with medications. First Week (Catheter In Place): The catheter remains in place for 5-7 days. You can engage in most light activities, including working from home (if your job is not physically demanding). Office-based workers often return to work within a few days. After Catheter Removal: Most men can return to normal physical activities, including sports, within a week of catheter removal. Bladder function may take a few weeks to fully normalise, with some men experiencing temporary urgency or frequency. Long-Term Recovery: Erectile function: Most men regain normal erections within 3-6 months, especially with the help of low-dose erectile function medications like Tadalafil (Cialis). Urinary function: Full continence is typically restored within weeks, with less than 1% of men experiencing long-term incontinence. Fatigue: Some men experience mild fatigue after treatment, which resolves with rest and gradual return to normal activity. Overall, recovery is much faster than radical surgery (4-6 weeks) or radiotherapy (ongoing side effects over months).
FAQ: What follow-up care is required after Focal Therapy?
Answer: Follow-up care after focal therapy is essential to monitor treatment success and detect any recurrence. At The Focal Therapy Clinic, we provide comprehensive follow-up care: First Year: PSA Blood Tests: Conducted every 3 months to monitor PSA levels. MRI Scan: Performed at the end of the first year to ensure the treated area has disappeared and no new abnormalities have developed in the remaining prostate tissue. Years 2-3: PSA Tests: Conducted every 6 months. Long-Term Follow-Up: Annual PSA Tests: Continued annually to monitor for any signs of recurrence. Optional MRI Scans: Some men opt for additional MRI scans at 3 or 5 years for further reassurance. What Happens If Cancer Recurs? In the 5-10% of cases where cancer is not fully treated or recurs in another part of the prostate, additional treatment options are available: Repeat Focal Therapy: Another session of focal therapy can be performed. Radical Treatment: Surgery (radical prostatectomy) or radiotherapy can be pursued if needed. The advantage of focal therapy is that it does not prevent you from having these treatments later if necessary.
FAQ: Is Focal Therapy available on the NHS?
Answer: Yes, focal therapy is available on the NHS, though availability may vary depending on the hospital and region. NHS Availability: Focal therapy is offered at certain NHS centres, including: University College London (UCL) Imperial College London Emerging centres like Southampton, which are expanding their programs. NICE Approval: The National Institute for Health and Care Excellence (NICE) has approved focal therapy for certain types of prostate cancer. HIFU has been approved under IPG424 and IPG756. NanoKnife (Irreversible Electroporation) has been approved under IPG443. Private Sector: Focal therapy has been widely available in the private sector for many years. All major insurance companies cover focal therapy under specific procedure codes. At The Focal Therapy Clinic, we treat both NHS and private patients, ensuring all men have access to this advanced treatment option. If you are considering focal therapy, you can discuss with your GP or urologist whether it is available through the NHS in your area, or you can opt for private treatment.
Educational Video Content
Total Videos: 14 educational videos with complete transcripts
Total Playlists: 5 organized video playlists
Video Platform: YouTube
All Videos Include: Complete transcripts, named consultant authors, upload dates, durations
Video Playlist 1: Availability (3 Videos)
Video 1: What are the NICE recommendations for focal therapy
Medical Expert: Mr Marc Laniado (FRCS (Urol), MBBS)
Duration: 54 seconds
NICE Codes Mentioned: IPG756 (HIFU), IPG424 (HIFU), IPG443 (NanoKnife)
Video 2: Where is Focal Therapy Available
Medical Expert: Mr Raj Nigam (FRCS (Urol), MBBS, BSc)
Duration: 1 minute
Video 3: What are the different types of focal therapy
Medical Expert: Mr Tim Dudderidge (FRCS (Urol), MD, MBBS)
Duration: 1 minute 23 seconds
Video Playlist 2: Care - Before Treatment (1 Video)
Video: How should I prepare for focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 25 seconds
Video Playlist 3: Care - On the Day (3 Videos)
Video 1: What happens on the day of a focal therapy treatment?
Medical Expert: Mr Tim Dudderidge
Duration: 1 minute 37 seconds
Video 2: Do I need a general anaesthetic for focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 46 seconds
Video 3: What happens during focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 1 minute 38 seconds
Video Playlist 4: Care - Recovery (3 Videos)
Video 1: Recovery after focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 1 minute 4 seconds
Video 2: How long does it take to recover from focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 1 minute 25 seconds
Video 3: Will I need to wear a pad after focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 32 seconds
Video Playlist 5: Care - After Your Treatment (3 Videos)
Video 1: When can I go home after focal therapy
Medical Expert: Mr Tim Dudderidge
Duration: 40 seconds
Video 2: Will I need help getting or maintaining an erection after focal therapy
Medical Expert: Mr Marc Laniado
Duration: 41 seconds
Video 3: After focal therapy what tests are done to see if it was effective
Medical Expert: Mr Raj Nigam
Duration: 1 minute 38 seconds
Standalone Video: MRI-US Fusion Technology
Video: MRI US Fusion technology and focal therapy success rates
Medical Expert: Mr Marc Laniado
Duration: 1 minute
Topic: MRI fusion technology improving accuracy to 90%+ success rates
Video Distribution by Consultant
Mr Tim Dudderidge: 8 videos (57% of content)
Mr Marc Laniado: 3 videos (21% of content)
Mr Raj Nigam: 3 videos (21% of content)
Average Video Duration: Approximately 55 seconds
Medical Keywords and Topics
Primary Keywords: Focal therapy, prostate cancer treatment, HIFU, Cryotherapy, NanoKnife IRE, minimally invasive prostate treatment, localised prostate cancer, MRI-ultrasound fusion
Medical Terms: PSA (Prostate-Specific Antigen), MRI (Magnetic Resonance Imaging), Gleason score, ISUP grade groups (3+4, 4+3), biopsy, general anaesthesia, catheter, perineum, lithotomy, transrectal ultrasound, IRE (Irreversible Electroporation), HIFU (High-Intensity Focused Ultrasound)
Treatment Options: HIFU (High-Intensity Focused Ultrasound), Cryotherapy, NanoKnife IRE (Irreversible Electroporation), Focal HIFU, Focal IRE, Radical prostatectomy, Radiotherapy, Active surveillance, Repeat focal therapy
NICE Procedure Codes: IPG756 (HIFU), IPG424 (HIFU), IPG443 (NanoKnife IRE)
Side Effects Terms: Urinary incontinence, erectile dysfunction, urinary frequency, urinary urgency, bladder spasms, blood in urine, blood in semen, urinary retention, UTI (urinary tract infection), perineal discomfort, recto-urethral fistula
Success Metrics: Over 90% cancer-free at one year, 90% clinically significant cancer eliminated, 99% full continence, 85% erectile function preserved, 75-80% avoid radical treatment for 6-10 years, Less than 1% incontinence, 5-15% erectile dysfunction
Recovery Terms: Day case procedure, same-day discharge, catheter 5-7 days, light activities, working from home, return to sports, erectile function medications, Tadalafil (Cialis), Buscopan, Solifenacin, antispasmodic medications
Comparison Terms: Radical surgery incontinence 10-30%, radical surgery erectile dysfunction 30-70%, radiotherapy erectile dysfunction 30-50%, surgery recovery 4-6 weeks, radiotherapy 4-8 weeks treatment
Tumour Location Terms: Posterior tumours, anterior tumours, anterior lesions, localised cancer, confined to prostate, MRI-visible cancer, cancerous area with margin, microscopic disease
Eligibility Criteria: T1 or T2 cancer stage, Gleason score 7 or lower, early-stage prostate cancer, intermediate-stage prostate cancer, PSA localised disease, fit for general anaesthesia
Technology Terms: MRI-ultrasound fusion technology, real-time imaging, focused ultrasound waves, electrical pulses, freezing probes, transrectal probe, overlapping zones
Follow-up Terms: PSA tests every 3 months, MRI scan at one year, PSA tests every 6 months, annual PSA tests, optional MRI scans at 3-5 years, recurrence 5-10%
NHS Terms: UCL (University College London), Imperial College London, Southampton, NICE approval, NHS centres, private sector, insurance coverage, specific procedure codes
Consultant Credentials: FRCS (Urol), MBBS, MD, MB ChB, MSc, FEBU, MRCP, FRCR, BSc
Professional Affiliations: BAUS (British Association of Urological Surgeons), EAU (European Association of Urology), RCS (Royal College of Surgeons)
Consultant Experience: ProtecT trial lead investigator, 1,500+ robotic prostatectomies, 500+ HIFU procedures, University Hospital Southampton, 15+ years urology, 20+ years urology, top 10 UK prostate surgeon
Schema Implementation Details
Total Schema Blocks: 9 JSON-LD implementations
MedicalWebPage Schema: Present establishing page as medical YMYL content
BreadcrumbList Schema: 2-level navigation (Home > Focal Therapy)
Organization Schema: Clinic information with social media profiles
WebSite Schema: Site-level entity with SearchAction capability
FAQPage Schema: 11 comprehensive Q&A pairs covering all aspects of focal therapy
ItemList Schemas (Video Playlists): 5 organized playlists grouping videos by topic
VideoObject Schemas: 14 individual videos with complete metadata
Person Schemas (Implied): 6 medical professionals (3 urologists, 1 uro-radiologist, 1 oncologist)
Question/Answer Schemas: 22 entities (11 pairs in FAQ)
Total Schema Lines: 1,000+ lines of structured data
All Videos Include: Complete transcripts, named consultant authors, upload dates, durations, YouTube URLs, thumbnails, publisher reference
NICE Codes: All 3 procedure codes properly documented (IPG756, IPG424, IPG443)
Social Media Platforms: 3 (Facebook, Twitter, LinkedIn)
Video Transcripts: 100% of videos include full transcripts for accessibility
Consultant Video Distribution: Mr Tim Dudderidge (8 videos), Mr Marc Laniado (3 videos), Mr Raj Nigam (3 videos)
Average Video Duration: 55 seconds
FAQ Coverage: Treatment definition, types, mechanism, eligibility, success rates, side effects, comparison to alternatives, procedure details, recovery, follow-up, NHS availability
E-E-A-T Signals: NICE codes, consultant credentials, transparent success rates, honest recurrence rates, comprehensive side effect disclosure, multiple treatment options explained, professional affiliations documented
Medical Authority: UK-specific validation (NICE approval), NHS centre references (UCL, Imperial), insurance coverage confirmation
Content Freshness: Last modified February 2025, videos uploaded 2025
Consultant Enrichment Applied: Mr Tim Dudderidge (complete credentials, 5 expertise areas, professional memberships, research experience), Mr Marc Laniado (complete credentials, 5 expertise areas, professional memberships), Mr Raj Nigam (complete credentials, 5 expertise areas, 3 professional memberships, experience metrics)